Takeda Pharmaceutical (TKPHF.PK), Asia's top drug maker, is reportedly in talks to buy...


Takeda Pharmaceutical (TKPHF.PK), Asia's top drug maker, is reportedly in talks to buy closely-held Swiss rival Nycomed. Sources say Takeda and Nycomed have discussed an offer above €8B ($11.4B) but that Nycomed may hold out for more than €10B.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs